IGlycine CAS 56-40-6 ye-Pharma Ibanga (USP / EP / BP)
Ukusetshenziswa:
IGlycine (Isifushaniso seGly) ingelinye lama-amino acid angama-20. Isetshenziswa kabanzi ezimbonini zemithi, zokuphakela nezokulungisa ukudla.
Njengesengezo sokudla, sisetshenziswa kakhulu njenge-flavouring, sweetener kanye ne-supplement yokudla okunempilo. Iphinde yengezwe ebhotela, ushizi nemargarini yokwandisa impilo yokugcina.
Njengesengezo sokuphakelayo, kuyengezwa kokuphakelayo ukukhulisa izifiso zezinkukhu nezilwane ezifuywayo, ikakhulukazi ezifuywayo.
Njengesithako esiphakathi kwemithi, i-Glycine isetshenziswa njengempahla eluhlaza ye-cephalosporin, i-aureomycin buffer, i-VB6 ne-Threonine njll kanye ne-thiamphenicol ephakathi. Lapho i-Glycine isetshenziswa ngokuhlangana ne-aspirin, inganciphisa ukucasuka esiswini. I-Glycine nayo iyasetshenziswa kwisisombululo somjovo se-amino acid njengokufakwa kokudla okunomsoco.
IGlycine futhi iyinto eluhlaza eyinhloko yokuhlanganiswa kweGlyphosate yokubulala ukhula.
1. I-Tech-Ibanga
(1) Isetshenziswa njenge-solvent yokususa i-CO2 embonini yomanyolo, njengesengezo kusixazululo se-galvanizing.
(2) Isetshenziswa njengesilawuli se-PH
(3) Isetshenziswa njengempahla yokhiye eluhlaza yeHerbicide Glyphosate.
2. Ibanga Lokudla / Lokuphakelayo
(1) Isetshenziswa njenge-flavouring, sweetener kanye ne-supplement yomsoco. Kusetshenziswe kuphuzo oludakayo, ukucutshungulwa kokudla kwezilwane nezitshalo, ekwenziweni kwemifino enosawoti kanye nezinsimbi ezimnandi.
(2) Njengesengezo sokwenza isosi enosawoti, uviniga nejusi yezithelo, ukuze kuthuthukiswe ukunambitheka nokunambitheka kokudla futhi kwandise umsoco wokudla.
(3) Njengesivikelo samakhekhe ezinhlanzi namajamu wamantongomane nesiqinisi sokhilimu, ushizi njll.
(4) Njenge-ejenti yokubhafa ukunambitheka kasawoti odliwayo neviniga.
(5) Isetshenziswa njengesengezo sokuphakelayo ukukhulisa izifiso zezinkukhu nezilwane ezifuywayo, ikakhulukazi ezifuywayo.
3.Pharm Ibanga
(1) Isetshenziswa kusixazululo somjovo we-amino acid njengokufakwa kokudla okunomsoco.
(2) Isetshenziswa njengomuthi wokwengeza ukwelapha i-myasthenia progressive and pseudo hypertrophic muscular dystrophy.
(3) Isetshenziswa njenge-ejenti yokwenza i-acid ekwelapheni i-neural hyperacidity kanye ne-gastric ulcer hyperacidity.
Imininingwane
| INTO | EP7.0 | BP2007 | USP39 | |
| Ukubukeka | Impuphu emhlophe yekristalu | Impuphu emhlophe yekristalu | - | |
| Ukubukeka kwesixazululo | kucace | kucace | - | |
| Ukuhlolwa kokuhlonza (okokuqala A, okwesibili B, C) | A | Kuze kube nguS. | Kuze kube nguS. | - |
| B | Kuze kube nguS. | Kuze kube nguS. | ||
| C | Kuze kube nguS. | Kuze kube nguS. | ||
| Ukuhlolwa kokuhlonza (Ukuhlolwa kwe-infrared spectrum) | - | - | Kuze kube nguS. | |
| Izinto ezi-ninhydrin-positive | Kuze kube nguS. | - | Kuze kube nguS. | |
| Assay | 98.5-101.0% | 98.5-101.0% | 98.5-101.5% | |
| I-chloride | ≤0.0075% | ≤0.0075% | ≤0.007% | |
| Izinsimbi ezisindayo (njenge-Pb) | ≤0.001% | ≤0.001% | ≤0.002% | |
| Sulfate | - | - | ≤0.0065% | |
| PH Inani | 5.9 ～ 6.4 | 5.9 ～ 6.4 | - | |
| Ukulahlekelwa kokomiswa | ≤0.5% | ≤0.5% | ≤0.2% | |
| Izinsalela zokushisa | - | - | ≤0.1% | |
| Izinto ezitholakala kalula ngamanzi | - | - | Kuze kube nguS. | |